Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Ferulic Acid.
A potent hydroxycinnamic acid derivative that functions as a free radical scavenger and inhibitor of lipid peroxidation, primarily utilized for its cardioprotective, neuroprotective, and dermatological photoprotective properties.
445858
194.18 g/mol
1.5
(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Ferulic Acid across standard consumer modalities.
The hygroscopic nature of ferulic acid requires the use of moisture-barrier excipients to prevent oxidative degradation and powder caking within the capsule shell.
The low pH of ferulic acid can interfere with the gelation kinetics of pectin-based matrices, potentially leading to structural instability or syneresis.
Significant payload limitations in thin-film matrices restrict ferulic acid to low-dose applications, while its phenolic bitterness requires advanced microencapsulation for effective taste masking.
Ready to launch a product featuring Ferulic Acid? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Ferulic Acid extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Ferulic Acid payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation